...-adapted algorithm with recommendations for treatment with FU-containing drugs. (iii) Testing may optionally be supplemented by therapeutic drug monitoring. The 2 oral prodrugs capecitabine and tegafur, which also hold marketing authorisations in Germany, Austria, and Switzerland, were developed from 5...

...Louai Alsaloumi; Shaima Shawagfeh; Abdikarim Abdi; Bilgen Basgut Background: Capecitabine is frequently used alone or combined with other chemotherapy agents for the treatment of metastatic breast cancer in relapsed patients. Objective: The objective of this meta-analysis is to evaluate...

...Qiuji Wu; Xinyuan Wang; Mengxi Zhang; Weiting Liao; Feng Wang; Qiu Li Background: The aim of the current study was to estimate two protocols for HER2-negative locally recurrent or metastatic breast cancer patients, bevacizumab combined with paclitaxel versus bevacizumab combined with capecitabine...

... (QoL) of patients treated with capecitabine as mono- or combination chemotherapy in an outpatient setting. Methods: Capecitabine was administered orally for 14 days of each 21-day cycle. The main parameters of interest were QoL, compliance, patient and physician satisfaction, handling of hand-foot...

... indicate that triplet combination regimens might improve outcome in the RAS/RAF-mutated subgroup. Patients and Methods: This retrospective analysis included 25 patients with metastatic colorectal cancer, who received treatment with OCX (oxaliplatin, irinotecan, capecitabine). The regimen consisted...